GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • American Association for Cancer Research (AACR)  (2)
  • 1
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 7 ( 2012-04-01), p. 1784-1794
    Abstract: Strategies to inhibit metastasis have been mainly unsuccessful in part due to insufficient mechanistic understanding. Here, we report evidence of critical role for the angiopoietin-like protein 2 (ANGPTL2) in metastatic progression. In mice, Angptl2 has been implicated in inflammatory carcinogenesis but it has not been studied in human tumors. In patients with lung cancer, elevated levels of ANGPTL2 expression in tumor cells within the primary tumor were associated with a reduction in the period of disease-free survival after surgical resection. Transcription factors NFATc, ATF2, and c-Jun upregulated in aggressive tumor cells promoted increased Angptl2 expression. Most notably, tumor cell–derived ANGPTL2 increased in vitro motility and invasion in an autocrine/paracrine manner, conferring an aggressive metastatic tumor phenotype. In xenograft mouse models, tumor cell–derived ANGPTL2 accelerated metastasis and shortened survival whereas attenuating ANGPTL2 expression in tumor cells–blunted metastasis and extended survival. Overall, our findings showed that tumor cell–derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process. Cancer Res; 72(7); 1784–94. ©2012 AACR.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2012
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 76, No. 14_Supplement ( 2016-07-15), p. 3542-3542
    Abstract: Background Giant cell tumors of bone (GCTs) are locally aggressive neoplasms composed of osteoclast-like giant cells and mononuclear cells. Mononuclear cells are accepted as true neoplastic elements, while osteoclast-like giant cells are non-neoplastic. However, close interaction between two cellular populations is indispensable for tumor formation. Large giant cells with hypermultinucleation of GCT are distinct from normal osteoclasts; however, their abnormality has not yet been sufficiently investigated. Recently, a germline mutation of the gene encoding autophagy-related protein p62/SQSTM1 was reported in Paget disease of bone, which implicates a role of autophagy in the differentiation and function of osteoclasts. In order to understand the relationship between autophagy and osteoclastogenesis in giant cell lesions, we studied clinical samples of GCTs and related tumors for immunoexpression of p62 (an autophagy flux marker), LC3 (an autophagosome marker), and Cathepsin K (a known osteoclastic marker). Design Formalin-fixed paraffin-embedded specimens of 46 GCTs, 17 chondroblastomas (CBLs), 3 giant cell reparative granulomata (GRGs), 3 chondromyxoid fibromas (CMFs) and one each of aneurysmal bone cyst (ABC) and brown tumor (BRT) were retrieved. Immunohistochemistry was performed by using antibodies against p62, LC3, and Cathepsin K. Results were scored as 3+ (strongly positive in ≥50% of cells), 1+ (weakly positive in & lt;10% of cells), 2+ (intermediate between 1+ and 2+), or 0 (negative). Giant cells and mononuclear cells were separately evaluated for nuclear and cytoplasmic staining. Results For giant cells, p62 was positive in a dot-like manner in all tumor types. Strong (3+) staining was found in nuclei and/or cytoplasms in GCTs (27/46, 59%), CBLs (14/17, 82%), GRGs (2/3, 67%), and other lesions (5/5, 100%). In addition, abnormal intracytoplasmic coarse aggregates were specifically noted in GCTs (21/46, 46%) and CBLs (3/17, 18%). In contrast, mononuclear cells showed a lower prevalence of 3+ p62 positivity in GCTs (2/46, 4%), CBLs (5/17, 29%), and an ABC (1/1), where positive cells were only presumable osteoclastic precursor cells around giant cells. LC3 showed a limited cytoplasmic 3+ positivity in giant cells of GCTs (6/46, 13%), CBLs (7/17, 41%), CMFs (1/3, 33%), and BRT (1/1). Cytoplasmic staining of Cathepsin K was constantly observed in giant cells. Conclusion Abnormal intracytoplasmic accumulation of p62 in a form of coarse staining aggregate characterizes giant cells of GCTs and CBLs. This finding may be a potential diagnostic marker for distinguishing GCTs and CBLs from other giant cell lesions. The presence of these p62 aggregates and low LC3 expression may indicate disturbance of autophagy-driven protein clearance. As p62 immunostain recognizes a wider osteoclastic population than Cathepsin K, p62 may be involved in abnormal osteoclastogenesis. Citation Format: Toru Motoi, Akihiko Yoshida, Noriko Motoi, Ikuma Kato, Tomotake Okuma, Akiko Tonooka, Shinichiro Horiguchi, Takahiro Goto, Tsunekazu Hishima. Abnormal intracytoplasmic accumulation of autophagy-related protein p62/SQSTM1 characterizes giant cells of giant cell tumor of bone. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3542.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2016
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...